The expression pattern of myeloblastin revealed a slightly diffuse cytoplasmatic staining that was restricted to certain cell types within the tumor, with a wide distribution of expression levels that correlate to the differences in expression levels that were found in the proteomics analysis (Figure 2O). This evidence concerns the gene PRTN3 and neoplasm.